QUEST GENOMICS
Quest Genomics is a tumor genetic testing instruments and reagents research and development company.
QUEST GENOMICS
Industry:
Biotechnology Health Diagnostics Medical Medical Device
Founded:
2012-11-01
Status:
Active
Contact:
025-83463509
Total Funding:
485.44 K USD
Technology used in webpage:
SPF Apache Euro Pound Sterling Japanese Yen Java EE GlobalSign HiChina DNS CNZZ Baidu Share
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Current Employees Featured
Yan Wang Chief Executive Officer & Chairman @ Quest Genomics
Chief Executive Officer & Chairman
Investors List
BUTTON CAPITAL
BUTTON CAPITAL investment in Series C - Quest Genomics
Hunan Jingfeng Pharmaceutical
Hunan Jingfeng Pharmaceutical investment in Angel Round - Quest Genomics
Lapam Capital
Lapam Capital investment in Angel Round - Quest Genomics
Ronglian Chuangfu
Ronglian Chuangfu investment in Angel Round - Quest Genomics
Cowin Capital
Cowin Capital investment in Angel Round - Quest Genomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-12-05 | Mandala | Quest Genomics investment in Series E - Mandala | 10 M CNY |
More informations about "Quest Genomics"
Genomic & Infrastructure Services | Quest Diagnostics
Whether screening for a common mutation or performing advanced analytics across the entire genome, next-generation sequencing has become an indispensable tool for clinicians, …See details»
Genetics - Quest Diagnostics
Streamlined workflows throughout every stage of testing to help enhance your organization’s efficiency; ... Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest …See details»
Quest Genomics - Crunchbase Investor Profile
Quest Genomics is a biotechnology research and development company. They provide products that include digital PCR and NGS-related equipment, …See details»
Quest Diagnostics Acquires Blueprint Genetics to Broaden Access …
Jan 22, 2020 Quest Diagnostics For further information: Kim Gorode, Quest Diagnostics (Media): 973-520-2800; Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900. Blueprint …See details»
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole …
Apr 2, 2024 Broad Clinical Labs is a leader in human whole genome sequencing, having sequenced over 600,000 genomes in service of its mission to accelerate the understanding …See details»
Quest genomics - 2025 Company Profile - Tracxn
Mar 28, 2025 Quest genomics is a deadpooled company based in Nanjing (China), founded in 2012. It operates as a Developer of digital PCR and NGS-related equipment, consumables …See details»
Quest Diagnostics and Blueprint Genetics to Present New Insights …
Apr 13, 2021 SECAUCUS, N.J. and HELSINKI, Finland, April 13, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and …See details»
Quest Genomics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 31, 2020: Series C - Quest …See details»
Partner with Genomic & Infrastructure Services - Quest Diagnostics
Working together to support your fully integrated genomics program Whatever your mission or ambition, Genomic & Infrastructure Services helps ensure that you have the tools, expertise, …See details»
Innovations and Insights - Quest Diagnostics
From conducting COVID-19 testing to examining emerging health trends, addressing diagnostic testing access, and making breakthroughs across molecular genomics and oncology, the work we do at Quest is nothing short of …See details»
Quest's vision for genomics at scale - Advisory
Aug 8, 2023 Advisory Board expert partner Devin Airey sat down with Mark Gardner, SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and …See details»
Quest Genomics (南京科维思生物科技股份有限公司) - 药物管线_ …
了解Quest Genomics (南京科维思生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Quest Genomics - Contacts, Employees, Board Members
Quest Genomics has 1 current employee profile, Chief Executive Officer & Chairman Yan Wang. Contacts. Edit Contacts Section. We're working on getting contact data for Quest Genomics . …See details»
Quest, Ultima Genomics Ink Oncology Diagnostics Collaboration
Jan 10, 2024 Quest Diagnostics will collaborate with Ultima Genomics to leverage Ultima’s NGS technology in oncology and other disease areas. ... Molecular Genomics and Oncology at …See details»
IBM Watson, Quest Diagnostics Launch Precision Oncology Service
Oct 18, 2016 The service—called IBM Watson Genomics from Quest Diagnostics ® —will consist of laboratory sequencing and analysis of a tumor’s genomic makeup designed to help …See details»
Advancing Precision in Genomics: Quest Diagnostics’ …
Mar 20, 2025 The 2025 ACMG (American College of Medical Genetics and Genomics) Annual Clinical Genetics Meeting in Los Angeles, CA will bring together leading experts to share …See details»
Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, …
MORRISVILLE, N.C. – June 3 2020 – Q 2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its …See details»
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole …
SECAUCUS, N.J., April 2, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Broad Clinical Labs, the world expert in whole genome …See details»
Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, …
MORRISVILLE, N.C.--(BUSINESS WIRE)-- Q 2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today …See details»
Quest Diagnostics to Collaborate with Google Cloud to Streamline …
Mar 18, 2025 SUNNYVALE, Calif. and SECAUCUS, N.J., March 18, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today …See details»